Latest Regulatory Compliance News

TruScreen Group reported a 42% increase in FY2026 sales driven by new market entries including India and Indonesia, alongside launching a large-scale cervical cancer screening program in Vietnam and submitting major UNITAID proposals.

Racura Oncology has locked in an underwriting agreement covering nearly 1.84 million expiring options, ensuring up to $2.3 million in fresh capital to back its cancer drug development programs.

Immuron Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information but pointing to a recent CEO presentation as a possible driver.

Beonic Ltd (ASX:BEO) has initiated a $3 million pro-rata renounceable entitlement offer at $0.08 per share, partially underwritten by Alpine Capital, to shore up working capital and repay shareholder loans. The offer carries potential dilution of 35.7% for non-participating shareholders and may increase the Thorney Group's voting power significantly.

Klevo Rewards takes a major step in building a regulated crypto-financial platform by partnering with Bybit and proposing key acquisitions to expand Fly Wallet’s digital asset and credit capabilities.

Harvest Technology Group secures a A$6.5 million two-tranche placement to fund its defence strategy, expand Nodestream, and strengthen its balance sheet ahead of key growth initiatives.

Australian Silica Quartz Group (ASQ) has cleared a key regulatory hurdle with DMPE approval for the White Swan Kaolin Project’s Mining Development and Closure Proposal, paving the way for bulk sampling and offtake talks ahead of mining.

DGR Global lodged a key director interest notice 14 days late due to an administrative slip, prompting an ASX compliance query. The company has outlined its existing governance measures and pledged refresher training to tighten disclosure controls.

Rural Funds Group has lodged replacement constitutions for its key trusts, Rural Funds Trust and RF Active, refining governance, stapling mechanics, and compliance frameworks to align with evolving regulatory standards.

CleanSpace Holdings expects modest revenue growth for FY26, hindered by product certification delays and global market challenges, while maintaining a strong cash position and preparing a new respirator launch.

Skin Elements Limited has lodged an application with the Takeovers Panel alleging undisclosed voting power exceeding 20% via a private placement, raising questions about shareholder rights ahead of critical board spill meetings.

Osteopore has secured Hainan FDA approval to clinically use and sell its custom orthopaedic devices at Shanghai Ruijin Hospital’s Hainan branch, marking a key step towards wider China market access. The company has scheduled its first patient surgery for June 2026.